Abstract
A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Current Pharmaceutical Analysis
Title: Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Volume: 4 Issue: 3
Author(s): Bo Yang, Yong Chen, Jun Lin and Yu Liu
Affiliation:
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Abstract: A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Export Options
About this article
Cite this article as:
Yang Bo, Chen Yong, Lin Jun and Liu Yu, Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives, Current Pharmaceutical Analysis 2008; 4 (3) . https://dx.doi.org/10.2174/157341208785161272
DOI https://dx.doi.org/10.2174/157341208785161272 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structure-Activity Relationships of N-benzylsalicylamides for Inhibition of Photosynthetic Electron Transport
Medicinal Chemistry Advances and Application of DNA-functionalized Nanoparticles
Current Medicinal Chemistry Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Preface [Hot Topic: Antimycobacterial Drugs: Current Status and Future Prospects (Executive Editor: Haruaki Tomioka)]
Current Pharmaceutical Design Serum Procalcitonin Levels in Febrile Patients with Systemic Autoimmune Diseases
Current Rheumatology Reviews Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Targeting Inhibition of COX-2: A Review of Patents, 2002 - 2006
Recent Patents on Inflammation & Allergy Drug Discovery The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents
Current Medicinal Chemistry Effect of Particle Formulation on Dry Powder Inhalation Efficiency
Current Pharmaceutical Design Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design
Current Medicinal Chemistry Effects of Edible Algae Polysaccharides on Allergic, Inflammatory, and Anti-Tumor Responses Through Toll-Like Receptor 4
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Influence of Cigarette Smoking on Sperm Quality and Sperm Membrane Integrity
Current Women`s Health Reviews Machine Learning and Social Network Analysis Applied to Alzheimer's Disease Biomarkers
Current Topics in Medicinal Chemistry Nanoparticle-Based Diagnosis and Therapy
Current Drug Targets Screening for Novel Antituberculosis Agents that are Effective Against Multidrug Resistant Tuberculosis
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Current Pharmaceutical Biotechnology Cheminformatics in Anti-Infective Agents Discovery
Mini-Reviews in Medicinal Chemistry Drug Susceptibility Testing for Optimizing Tuberculosis Treatment
Current Pharmaceutical Design